New Tetraphenylethylene Benzoic Acid Derivatives as Antibacterial Agents for Gram-Positive Bacteria with Ultralow Inhibition Concentration
Bioconjugate Chemistry · 2025
DOI: 10.1021/acs.bioconjchem.5c00448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Xuefan Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, P. R. China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Staphylococcus aureus, Stilbenes, Benzoic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing University of Chemical Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
The misuse of antibiotics has intensified the emergence of drug-resistant bacteria. The diversity of chemical structures offers a crucial foundation for developing novel small-molecule antibacterials. New chemical scaffolds may hold significant potential for combating drug-resistant bacteria. In this study, a series of benzoic acid derivatives featuring a tetraphenylethylene (TPE) core were designed to modulate their pKa by incorporating various electron-donating and electron-withdrawing groups. This approach led to the development of a series of effective Staphylococcus aureus therapeutic agents. Among these compounds, the nitro-substituted tetraphenylethylene benzoic acid derivative (NOA) exhibits an ultralow minimum inhibitory concentration (MIC = 0.04 μg/mL) against S. aureus, while MIC of the traditional antibiotic vancomycin was 0.13 μg/mL. NOA achieved a 99% elimination rate of S. aureus at a 0.16 μg/mL and displayed antibacterial activity against S. aureus biofilm at 0.32 μg/mL. NOA could effectively treat wound infections caused by S. aureus in infected mouse models. This study provides valuable advice about the chemical substituents for designing new antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, P. R. China.
- Department of Synthetic Resins, PetroChina Petrochemical Research Institute, Beijing 102206, P. R. China.
- Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
ORCID-Profile: Zhuo Wang
Förderung
- National Key Research and Development Program of China
- Beijing University of Chemical Technology
- National Natural Science Foundation of China
- PetroChina
Zitieren
APA
Guo, X., Peng, Y., Zhang, M., Wang, K., Zhang, G., Li, J., Zhang, Z., Li, R., & Wang, Z. (2025). New Tetraphenylethylene Benzoic Acid Derivatives as Antibacterial Agents for Gram-Positive Bacteria with Ultralow Inhibition Concentration. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00448
Vancouver
Guo X, Peng Y, Zhang M, Wang K, Zhang G, Li J, et al. New Tetraphenylethylene Benzoic Acid Derivatives as Antibacterial Agents for Gram-Positive Bacteria with Ultralow Inhibition Concentration. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.5c00448
BibTeX
@article{Guo2025,
author = {Guo, Xuefan and Peng, Yanghan and Zhang, Mingge and Wang, Kunyi and Zhang, Guoyang and Li, Jiguang and Zhang, Zixuan and Li, Rongbo and Wang, Zhuo},
title = {New Tetraphenylethylene Benzoic Acid Derivatives as Antibacterial Agents for Gram-Positive Bacteria with Ultralow Inhibition Concentration},
journal = {Bioconjugate Chemistry},
year = {2025},
doi = {10.1021/acs.bioconjchem.5c00448}
}
EUVIMED